Insight Pharma Reports Market Research Reports

TITLE Actions
Cancer Immunotherapy: Building on Initial Successes to Improve Clinical Outcomes
Published in May 2017 | US $ 2495 Onwards | By Insight Pharma Reports

Highlights of this Report Include: Approvals of checkpoint inhibitors Biomarkers for checkpoint inhibitor treatments Approved and clinical-stage immunotherapy biologics other than checkpoint inhi...

The Human Microbiome: Advancing New Frontiers in a Rapidly Emerging Market
Published in Jan 2016 | US $ 2495 Onwards | By Insight Pharma Reports

The field of Human Microbiome research and development is apparently one of the most popular hubs of the biotechnology industry. While the Human Microbiome Project, MetaHIT and other huge studies of human microbiota, have garnered a lot of attenti...

Combination Antibody Therapy for Cancer Treatment Overview
Published in Jan 2016 | US $ 2495 Onwards | By Insight Pharma Reports

Recombinant antibodies have been the shining jewels in the firmament of the pharma industry for almost the last two decades. They have returned billions of dollars in sales, and if their performance has not been the unalloyed triumph that was fore...

Gene Therapy: Moving Toward Commercialization
Published in Nov 2015 | US $ 2495 Onwards | By Insight Pharma Reports

Insight Pharma Reports’ Gene Therapy: Moving Toward Commercialization”, outlines the progress of the gene therapy field since its inception in the 1970s, with a special focus on clinical-stage gene therapy programs tha...

Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks Overview
Published in Oct 2015 | US $ 2495 Onwards | By Insight Pharma Reports

New to Insight Pharma Reports is Digital Pathology Insights:  Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks. This report delves into the rapidly evolving field of digital pathology, briefly reviewing the und...

Biomanufacturing Capacity Strategies: Developing a Flexible, Scalable and lean Biomanufacturing system - Overview
Published in Aug 2015 | US $ 1995 Onwards | By Insight Pharma Reports

The newly published Insight Pharma Reports, Biomanufacturing Capacity Strategies: Developing a Flexible, Scalable, and Lean Biomanufacturing System Report, focus on the need for a more reactive and dynamic biomanufacturing approach than is the cur...

Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview
Published in Jun 2015 | US $ 1995 Onwards | By Insight Pharma Reports

Available to Insight Pharma Reports is Ocular Disorders: Rising Therapeutics, Technologies, and Devices Report. This report begins with outlining Age-related macular degeneration (both wet and dry) and delving into Anti-VEGF therapies in chapter 2...

Prenatal Diagnostic Testing - Overview
Published in Apr 2015 | US $ 2495 Onwards | By Insight Pharma Reports

New to Insight Pharma Reports is Prenatal Diagnostics: Invasive Testing, Noninvasive Testing, and Rising Maternal Screening Methods for Preeclampsia and Preterm Labor. This report discusses improvements in invasive procedures (karyotyping vs. cyto...

Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management
Published in Feb 2015 | US $ 2495 Onwards | By Insight Pharma Reports

OverviewCancer diagnostics based on measuring biomarkers in tissue samples has already in the past decade provided revolutionary advances in diagnosis, prognosis, and therapy selection. A major drawback of the tissue-based ...

The Human Microbiome: Biomedical Implications and Birth of a Market
Published in Oct 2014 | US $ 2495 Onwards | By Insight Pharma Reports

OverviewPublished in October, 2014, is Insight Pharma Reports' The Human Microbiome: Biomedical Implications and Birth of a Market. This report covers the evolution of microbiome research and its growth in the commercia...

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies
Published in Sep 2014 | US $ 2495 Onwards | By Insight Pharma Reports

OverviewThis report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians and patient...

Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders
Published in Jul 2014 | US $ 2495 Onwards | By Insight Pharma Reports

OverviewBiomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders has a focus in biomarkers for neurodegenerative diseases and diagnostic applications in development. Biomarkers have bee...

Molecular Diagnostics: An Insight to Rising Markets and Trends in Cancer and Prenatal Technologies
Published in May 2014 | US $ 2495 Onwards | By Insight Pharma Reports

Molecular Diagnostics: An Insight to Rising Markets and Trends in Cancer and Prenatal Technologies covers market research, relevant disease background, and a number of rising technologies available to physicians and clinicians in the cancer and pr...

Vaccines: The End of Illness
Published in Apr 2014 | US $ 2495 Onwards | By Insight Pharma Reports

This report focuses on the most recent vaccine research, emphasizing their reputation as an unmatched tool of efficient healthcare. Their low cost, extended protection and the impossibility of their circumvention through development of resistance ...

MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics
Published in Apr 2014 | US $ 2495 Onwards | By Insight Pharma Reports

This report covers the specifics of microRNA (miRNA) as it is a relatively new space in heavy pursuit of research due to its versatility and stability, properties that are unique to miRNAs compared to other RNA components. miRNA's non-coding n...

We are on:

Need Help?

Avail 15% Discount, Use JULY15 Coupon Code